[Form 4] Bio-Techne Corp. Insider Trading Activity

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

4

Rhea-AI Filing Summary

Analyzing...

Insights

Analyzing...

07/17/2025 - 05:04 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Bio-Techne Corp

NASDAQ:TECH

TECH Rankings

#1263 Ranked by Market Cap

#1960 Ranked by Dividends

TECH Latest News

Jul 17, 2025

Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results

Jul 15, 2025

Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology

Jul 15, 2025

Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection

Jul 14, 2025

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

Jun 24, 2025

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

TECH Stock Data

Market Cap 8.24B

Float 155.09M

Insiders Ownership 1.05%

Institutions Ownership 101.12%

Short Percent 3.33%

Industry Biotechnology

Sector Biological Products, (no Disgnostic Substances)

Website Link

Country United States

City MINNEAPOLIS